Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: October 08, 2018
Targeting nucleolin for better survival in diffuse large B-cell lymphoma.
Journal: Leukemia
Published: September 21, 2016
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
Journal: Journal of translational medicine
Published: July 27, 2016
Resolution of lung adenocarcinoma after discontinuation of ibrutinib.
Journal: BMJ case reports
Published: July 21, 2016
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Journal: Haematologica
Published: March 07, 2016
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Journal: British journal of haematology
Published: December 16, 2014
HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
Journal: Molecular cancer research : MCR
Published: May 05, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026